Back to Screener

Healthcare

Maze Therapeutics, Inc.(MAZE)

Live Price

Offline

$28.43

+5.22% today

1Y Change

+102.44%

Window

Jun 30, 2025 โ†’ Jun 17, 2026

Market Cap
$1.50B
Revenue Growth
-100.0%
EPS Growth
-4020.3%
Dividend Yield
0.0%

Coverage: 243 bars ยท Jun 30, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Maze Therapeutics, Inc. (MAZE) is a Healthcare stock with a market cap of $1.50B and listed on NASDAQ. The stock last traded around $28.43 and up 102.4% across the available one-year price window (Jun 30, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of -4020.3%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS -4020.3%, free cash flow -250.7% with operating margin 0.0% and ROIC -37.7%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MAZE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

MAZE vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

MAZE is 82.52 pts ahead over the shared 1Y window.

MAZE had 45.38 pts deeper max drawdown than SPY.

MAZE beat SPY in 1 of 2 calendar years shown and trailed in 1.

MAZE

+102.44%

Normalized return

SPY

+19.93%

S&P 500

Excess Return

+82.52 pts

Relative to SPY

MAZE Max Drawdown

-54.51%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

MAZESPY

Calendar-Year Returns

Uses the longest available daily history for MAZE and SPY.

YearMAZESPYExcessLeader
2026-37.54%+6.71%-44.25 ptsSPY
2025+226.41%+11.19%+215.21 ptsMAZE

Earnings Reports

๐Ÿ“… Last reportedMay 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 13, 26
โ€”
Est -0.63
โ€”
โ€”
Est 8572.1B
โ€”
May 13
โ€”
Mar 25, 26
โœ“
-0.65
Est -0.73
+11.0%
โ€”
Est 375.0B
โ€”
Mar 25
โ€”
Nov 6, 25
โœ“
-0.66
Est -0.74
+10.8%
โ€”
Est โ€”
โ€”
Nov 6
โ€”
Aug 12, 25
โœ“
-0.77
Est -0.79
+2.5%
โ€”
Est 3125.0B
โ€”
Aug 12
โ€”
May 14, 25
โœ—
-1.15
Est -0.76
-51.3%
โ€”
Est โ€”
โ€”
May 14
โ€”
Mar 31, 25
โœ—
-18.32
Est 0.45
-4171.1%
โ€”
Est โ€”
โ€”
Mar 31
โ€”
Sep 30, 24
-0.57
Est โ€”
โ€”
2500.0B
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 24
3.18
Est โ€”
โ€”
165000.0B
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 24
-0.74
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 23
-0.61
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 23
-0.57
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar